Showing 19,841 - 19,860 results of 101,167 for search '(( 5 step decrease ) OR ( 5 ((nn decrease) OR (((mean decrease) OR (a decrease)))) ))', query time: 1.73s Refine Results
  1. 19841

    <b>Predictors of initial and sustained glycemic and weight response to tirzepatide: a post hoc analysis of SURPASS-4</b> by Ewan R. Pearson (157520)

    Published 2025
    “…For tirzepatide-treated participants achieving HbA1c ≤48 mmol/mol (6.5%) at 52 weeks, 75-84% sustained this until study end (median: 81 weeks). …”
  2. 19842

    Data and code from: Continental declines in North American small mammal populations by Alec Medd (20968740)

    Published 2025
    “…url=https://doi.org/10.1016/j.biocon.2025.111109&data=05|02|Amanda.Martin@ec.gc.ca|925abea0a03740253ae708dd70789ae4|740c5fd36e8b41769cc9454dbe4e62c4|0|0|638790385495205807|Unknown|TWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydWUsIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ==|0|||&sdata=MMoCJR/Opug1h8f4AzQ+Gnr3pd2LNkGwV2yvMEUf6cU=&reserved=0" target="_blank">https://doi.org/10.1016/j.biocon.2025.111109</a><b>) for full details.…”
  3. 19843

    BMP7v reduced vascularization <i>in vivo</i>. by Courtney M. Tate (555115)

    Published 2015
    “…In vehicle injected mice, the tumors progressively increased their diameter from 9.9 + 0.74 mm (mean + SEM) at Week 1 to 21 + 1.6 mm at Week 5. Statistically significant (<i>p</i><0.05) decreases in tumor size were observed at the 4 and 5 week measurements with 0.1 μg BMP7v treatment and (<i>p</i><0.01) at the 2, 3, 4, and 5 week timepoints with 1 μg BMP7v compared to vehicle controls (CNTR). …”
  4. 19844

    Relationship between mean annual precipitation and the absolute and relative change in soil organic carbon (SOC) in younger and older plantations. by Ruiying Chang (332787)

    Published 2014
    “…Positive values indicate an increase in the SOC stock due to afforestation, and negative values indicate a decrease.</p>…”
  5. 19845

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  6. 19846

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  7. 19847

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  8. 19848

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  9. 19849

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  10. 19850

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  11. 19851

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  12. 19852

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  13. 19853

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  14. 19854

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  15. 19855

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  16. 19856

    Tandem Imaging of Breath Ethanol and Acetaldehyde Based on Multiwavelength Enzymatic Biofluorometry by Kenta Iitani (4175995)

    Published 2024
    “…Reduction of AcH by ADH<sub>RD</sub> consumed NADH, leading to a decrease in blue fluorescence (ex. 340 nm, fl. 490 nm). …”
  17. 19857
  18. 19858

    Age- and gender-adjusted marginal mean cholesterol levels (mg/dl) by DENV infection status and day of illness. by Hope H. Biswas (179729)

    Published 2015
    “…In contrast, HDL-C levels were significantly lower only on days 5–7 of illness (p<0.001). HDL-C levels followed a similar trajectory among both dengue-positive and dengue-negative patients, decreasing from day 2 to day 6–7 of illness before stabilizing or increasing slightly on day 7–8 of illness. …”
  19. 19859
  20. 19860

    With progressing vaccination in the European Union, a slow but steady increase in freedom will be possible. However, premature lifting of NPIs considerably increases the total fata... by Simon Bauer (11378195)

    Published 2021
    “…The other extreme (Scenario 5) uses a strong initial reduction in contacts to allow long-term control at low case numbers. …”